Haemonetics Corp Q2 Profit Surges, Backs FY14 View - Quick Facts

(RTTNews) - Haemonetics Corp. (HAE) Monday reported a surge in its second-quarter net income, reflecting increase in revenues.

For the three-month period, the company reported net income of $16.5 million or $0.32 per share, compared with $6.5 million or $0.13 per share a year ago. Excluding transformation, integration and deal amortization expenses, adjusted net income was $34.4 million or $0.66 per share for the quarter.

On average, nine analysts polled by Thomson Reuters expected the company to report earnings per share of $0.57 for the quarter. Analysts' estimates typically exclude one-time items.

Net revenue rose 8 percent to $235.8 million, from prior year's $218.1 million. Analysts expected the company to generate revenues of $239.63 million for the quarter.

For the full year 2014, the company reaffirmed adjusted earnings expectations to be in the previously-provided range of $2.30 to $2.40 per share. Analysts expect the company to report earnings of $2.34 per share for the year.